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Supplementary Methods 
Animals and Ethics Statement 
 Adult and newborn (at postnatal day 5) male Crl:NMRI BR mice were used in the experiments 
(purchased from Toxi-Coop, Budapest, Hungary). Animals were housed under standard laboratory 
conditions (12:12 h light–dark cycle, with free access to water and food). The care and treatment of all 
animals conformed to guidelines approved by Council Directive 86/609/EEC and the Hungarian Act of 
Animal Care and Experimentation (1998, XXVIII) as well as with local regulations for the care and use 
of animals for research. All efforts were taken to minimize the animals’ pain and suffering and to reduce 
the number of animals used. 
 
Whisker Removal and Isolation of the Barrel Cortices 
 All of the whiskers on the right-hand side of the mice were plucked and trimmed under 
isoflurane anesthesia. To maintain sensory deprivation, the possibly regrown whiskers were trimmed 48 
h after the initial whisker removal. 72 h after the initial whisker removal, mice were sacrificed via 
cervical dislocation and their brains were quickly removed and briefly washed in ice-cold artificial 
cerebrospinal fluid (ACSF). The primary somatosensory barrel cortices from both hemispheres were 
dissected using vascular landmarks (1). Synaptosome fractions were immediately prepared from the 
isolated barrel cortices as described below.  
 
Preparation of the Whole Tissue Samples and the Synaptosome Fraction 
 The mice were sacrificed via cervical dislocation and their brains were quickly removed from 
their skulls. The whole brains were briefly washed in ice-cold ACSF to remove blood contamination, 
the cerebral cortices were dissected, and then were collected. In another investigation, transcardial 
perfusion of mice was performed with ice-cold ACSF after urethane anesthesia. The perfusion procedure 
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was followed by the rapid removal of the brains, and then the dissection and collection of cerebral 
cortices. 
 The preparation of the whole cortical tissue samples was started with their mechanical 
homogenization using a Sample Grinding Kit (GE Healthcare, Little Chalfont, UK) in lysis buffer (7 M 
urea, 2 M thiourea, 4% (wt/vol) CHAPS, 20 mM Tris, 5 mM magnesium-acetate). Next, the samples 
were centrifuged at 14,000 × g at 4 °C for 1 h and the supernatants were acetone-precipitated overnight 
at -20 °C. The protein precipitates were resuspended in lysis buffer and stored at -80 °C. 
 The subcellular fractionation has been started immediately after the brain removal. The fraction 
of synaptosomes (2) was prepared strictly following the protocol published by Phillips et al. (3) and 
Hahn et al. (4). Briefly, cerebral cortices from both hemispheres were first homogenized in an isoosmotic 
sucrose solution. Subsequently, samples were ultracentrifuged in a tube with two sucrose media with 
different densities. Synaptosomes were collected from the interface between the two sucrose layers. The 
proteins of those synaptosomes which were not fractionated further, were acetone-precipitated overnight 
at -20 °C, resuspended in lysis buffer and stored at -80 °C. 
 
Preparation of Pre- and Postsynaptic Membrane Fractions 
 Synaptosome fractions were processed to separate pre- and postsynaptic membranes. A full 
description of the protocol is presented by Hahn et al. (4). Briefly, synaptosomes were first disrupted 
with the combination of mechanical homogenization and detergent treatment. Synaptic junctions were 
isolated with detergent treatment and incubation in a buffer at pH 6. Finally, pre- and postsynaptic 
membrane elements were separated with a final detergent treatment and incubation at pH 8, followed 
by ultracentrifugation to pellet the more compact, postsynaptic density-associated postsynaptic 
membrane, and leaving the presynaptic membrane-associated presynaptic active zone in the supernatant. 
Proteins of both fractions were acetone-precipitated overnight at -20 °C and resuspended in lysis buffer. 
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Electron Microscopy 
 Synaptosome samples were fixed in 2% formaldehyde, 1% glutaraldehyde in 0.1 M sodium 
cacodylate buffer, pH 7.4 for 30 min at room temperature (RT). Subsequently, the samples were 
extensively washed in the above buffer and postfixed in 0.5% osmium tetroxide, 0.75% potassium 
hexacyanoferrate for 45 min, en bloc stained with aqueous uranyl acetate for 30 min, dehydrated and 
embedded in LR White resin (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer’s 
instructions. Ultra-thin sections (70 nm) were collected on formvar coated single slot copper grids 
(Sigma-Aldrich) and stained with lead citrate for 30 s. Grids were examined with a JEM-1011 electron 
microscope (JEOL, Tokyo, Japan) operating at 60 kV. Images were taken from different mesh along a 
longitudinal band to cover the entire width of the specimen. 
 
Isolation of Mouse C1q Protein 
 Mouse C1q was isolated from Biowest Mouse Serum (Biowest, Nuaillé, France) by a 2-step 
purification method, including affinity and ion-exchange chromatography based on the protocol of 
Kojouharova (5). Each step of the protocol was carried out at 4 °C. A 10-mL affinity chromatography 
column was prepared by coupling 15 mg/mL human IgG (human polyclonal IgG1 was a gift of Péter 
Závodszky (Institute of Enzymology)) to CNBr-activated Sepharose-4B matrix (GE Healthcare) 
according to the manufacturer’s instructions. The IgG affinity chromatography was performed in 20 
mM Tris-HCl buffer, pH 7.0 containing 120 mM NaCl and 20 mM EDTA. After thawing, the mouse 
serum was diluted twice in the equilibration buffer containing 0.2 mM PMSF, filtered through 0.45-µm 
syringe filter (VWR International, Radnor, PA, USA) and loaded to the IgG affinity column. Proteins 
bound to the human IgG were eluted by increasing the ion strength and pH (50 mM Tris-HCl, 1 M NaCl, 
20 mM EDTA, pH 10.0) in one step. The C1q-containing fractions were dialyzed overnight against 20 
mM HEPES buffer, pH 7.8, containing 60 mM NaCl and 10 mM EDTA. The same buffer was used to 
equilibrate a 1-mL HiTrap SP HP column (GE Healthcare). The dialyzed sample was loaded to the 
strong cation exchange column and elution was achieved by using 20-mL increasing NaCl gradient (20 
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mM HEPES, 700 mM NaCl, 10 mM EDTA, pH 7.8). The mouse C1q was found to elute at ~200 mM 
NaCl and the C1q-containing fractions were dialyzed overnight against 50 mM NaH2PO4 buffer, pH 
7.4, containing 100 mM NaCl. Finally, 30% ethylene glycol was added to the isolated mouse C1q and 
small aliquots of the protein were stored at -80 °C. To test whether the isolated C1q remained intact, we 
performed analytical size-exclusion chromatography on a 24-mL Superose-6 Prep Grade column (GE 
Healthcare) equilibrated with the latter dialysis buffer. The mouse C1q was found to be intact, even after 
thawing the frozen samples. The purity of the protein was also verified by SDS-PAGE. 
 
Western Blot 
 Protein concentrations of whole tissue samples, synaptosome, and pre- and postsynaptic 
fractions were determined using 2-D Quant Kit (GE Healthcare). Samples, containing equal amounts of 
proteins, were diluted with equal volume of two-fold concentrated sample buffer (8% (wt/vol) SDS, 3% 
(wt/vol) dithiothreitol (DTT), 24% (vol/vol) glycerol, 0.2% (wt/vol) bromophenol blue, 100 mM Tris-
HCl, pH 6.8), and incubated for 5 min at 96 °C. Tricine-SDS PAGE was conducted following the 
protocol of Schägger (6). After gel electrophoresis, proteins were transferred onto Hybond LFP PVDF 
membrane (GE Healthcare). Blots were stained with the highly sensitive SYPRO Ruby total protein blot 
stain (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s instructions as 
loading control when minute amounts of sorted synaptosomal samples were used. Membranes were 
blocked with 5% bovine serum albumin (BSA) in Tris-buffered saline (TBS) containing 0.05% Tween-
20, and then incubated overnight at 4 °C with primary antibodies depending on the experiment as 
follows: anti-C1qA (1:200 dilution; catalogue number: sc-25856; Santa Cruz Biotechnology, Dallas, 
TX, USA), anti-synaptophysin (anti-Syp; 1:100 dilution; catalogue number: sc-55507; Santa Cruz 
Biotechnology), anti-Psd95 (1:2,000 dilution; catalogue number: 04-1066; Merck Millipore, Billerica, 
MA, USA), anti-cleaved caspase-3 (1:1,000 dilution; catalogue number: STJ97448; St John’s 
Laboratory, London, UK), and anti-actin (1:1,000 dilution; catalogue number: ab1801; Abcam, 
Cambridge, UK) as loading control. Membranes were washed with 0.05% Tween-20 in TBS, and then 
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incubated for 2 h at RT with anti-rabbit, Cy5-conjugated and anti-mouse, Cy3-conjugated secondary 
antibodies (1:2,500-1:2,500 dilution; catalogue numbers: PA45011 and PA43009, respectively; GE 
Healthcare) depending on the host species of the primary antibodies. Subsequently, membranes were 
washed with 0.05% Tween-20 in TBS, and the fluorescence was detected with a Typhoon TRIO+ 
scanner (GE Healthcare) using appropriate lasers and filters. Analysis of images was conducted with 
ImageJ software (http://rsbweb.nih.gov/ij, National Institutes of Health, Bethesda, MD, USA). 
Statistically significant differences were determined with two-tailed Student’s t-test of paired or 
independent samples depending on the experiments. 
 In order to identify different neuronal pentraxin 1 (Nptx1) protein spots, 2D-immunoblotting 
was performed. Synaptosomal homogenate containing 1 mg total protein was subjected to traditional 
2D gel electrophoresis comprising isoelectric focusing and protein separation by molecular weight (also 
see the section “Proteomics Experiments”). Subsequently, proteins were transferred to a PVDF 
membrane. Total protein content was stained using SYPRO Ruby Protein Blot Stain strictly following 
the manufacturer’s instructions. The staining pattern was visualized using a Typhoon TRIO+ scanner. 
Finally, neuronal pentraxin 1 (Nptx1) protein spots were identified using anti-Nptx1 primary (1:200 
dilution; catalogue number: 20656-1-AP; Proteintech, Rosemont, IL, USA), and anti-rabbit, Cy5-
conjugated (1:2,500 dilution; GE Healthcare) secondary antibodies as described above, and then 
visualized using a Typhoon TRIO+ scanner. 
 
Immunolabeling of Synaptosomes and Assessment of Apoptotic Processes and Viability 
 Synaptosomes, stored at 4 °C, were immunolabeled the next day after the subcellular 
fractionation. Initially, the synaptosome fraction was immunolabeled in phosphate-buffered saline, 
which caused significant aggregation of synaptosome sub-populations. This aggregation enabled the 
visualization of large groups of synaptosomes even by light microscopy. However, after the preliminary 
investigations of this synaptic fraction, the labeling procedure was carried out in 320 mM sucrose, 1 
mM EDTA, 5 mM Tris, pH 7.4 buffer (SET buffer). This medium has been proven to be optimal for the 
prevention of synaptosome aggregation (7), which would essentially compromise the flow cytometry 
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experiment. First, synaptosomes were gently fixed with 0.25% formaldehyde for 1 h at 4 °C, which 
promotes sufficient mechanical stability of the synaptosomes without deteriorating antigen-antibody 
interactions (8). Aspecific protein binding was blocked by incubating the samples with 1% BSA for 30 
min at RT. Synaptosomes were incubated with anti-C1qA (1:30 dilution; catalogue number: sc-25856; 
Santa Cruz Biotechnology) or anti-C1q (1:30 dilution; catalogue number: 182451; Abcam) primary 
antibodies for 30 min at RT, followed by two washing steps to remove unbound antibodies. Next, we 
incubated the suspension for 30 min at RT with anti-rabbit secondary antibody, conjugated with Cy5-
fluorochrome (1:1,500 dilution; catalogue number: PA45011, GE Healthcare). When additional labeling 
of the intracellular Syp and cleaved caspase-3 proteins was conducted, a gentle permeabilization was 
applied after two additional washing steps via incubation of the samples in the SET buffer with 0.2% 
Tween-20 for 15 min at 37 °C. Subsequently, permeabilized samples were incubated with either anti-
Syp (1:50 dilution; catalogue number: sc-55507; Santa Cruz Biotechnology) or anti-cleaved caspase-3 
(recognizing only the ~17 kDa fragment of caspase-3 once activated; Supplementary Fig. S7) (1:100 
dilution; catalogue number: STJ97448; St John’s Laboratory, London, UK) antibodies depending on the 
experiment for 30 min at RT, which was followed by two washing steps. Permeabilized samples then 
were incubated with anti-mouse, Alexa Fluor 488-conjugated secondary antibody (1:1,000 dilution; 
catalogue number: A11001; Thermo Fisher Scientific), and then synaptosomes were washed. Samples 
(non-permeabilized and permeabilized as well) were filtered through a 5.0-µm Durapore membrane 
filter (Merck Millipore) to remove non-synaptosomal debris and other contaminations. Annexin V 
labeling was performed before filtering using annexin V-FITC protein (catalogue number: 640906; 
BioLegend, San Diego, CA, USA) in annexin V binding buffer (eBioscience, San Diego, CA, USA) 
according to the manufacturer’s instructions. For viability tests, calcein-AM (catalogue number: C3099; 
Thermo Fisher Scientific) was applied also before the filtering procedure according to the 
manufacturer’s instructions when experiments were conducted to assess the viability of synaptosomes. 
Finally, 0.5% Pluronic F-68 detergent (Thermo Fisher Scientific) was added to prevent the aggregation 
of synaptosomes. 
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Confocal Microscopy 
 Examinations on synaptosomes were conducted using a FluoView 500 laser scanning confocal 
microscope (Olympus Europe, Hamburg, Germany) with an argon-ion laser (with 488 nm excitation 
wavelength) and with two helium-neon lasers (with 543 and 632 nm excitation wavelengths) operated 
by the FluoView 5.0 software (Olympus Europe). Image acquisition was performed with a 60x objective 
(1.1 NA; Plan Apochromat) in DIC and fluorescence modes. Image-processing was conducted using 
FluoView 5.0 and ImageJ softwares.  
 
Immunofluorescence Staining of Mouse Brain Sections 
 Mice were anesthetized with urethane and transcardially perfused first with 0.1 M phosphate 
buffer (PB), pH 7.4, and then with 2% formaldehyde, 0.1 M PB. Subsequently, the brains were quickly 
removed and post-fixed in the same fixative solution for 3 h at RT. After replacing the fixative solution 
to 0.1 M PB, 60 µm sagittal brain sections were produced with a vibratome. Brain sections were washed 
with 0.1 M PB and stored in the same buffer supplemented with 0.1% sodium azide at 4 °C. At the 
beginning of the immunostaining procedure, the 0.1 M PB, 0.1% sodium azide solution was replaced 
with TBS and sections were blocked in blocking buffer (150 mM NaCl, 50 mM Tris, 100 mM L-lysine, 
3% BSA, 0.2% Triton X-100, pH 7.4) for 45 min at RT. For triple immunostaining, sagittal brain 
sections were incubated in primary antibody buffer (150 mM NaCl, 50 mM Tris, 100 mM L-lysine, 1% 
BSA, pH 7.4) with anti-C1q (1:1,000 dilution; catalogue number: 182451; Abcam), anti-cleaved 
caspase-3 (1:100 dilution; catalogue number: STJ97448; St John’s Laboratory), and anti-Syp (1:500 
dilution; catalogue number: 101 006; Synaptic Systems, Göttingen, Germany) primary antibodies for 48 
h at 4 °C. After several washing steps with TBS, the sections were incubated with anti-rabbit, Alexa 
Fluor 546-conjugated (1:250 dilution; catalogue number: A-11010; Thermo Fisher Scientific), anti-
mouse, Alexa Fluor 514-conjugated (1:250 dilution; catalogue number: A-31555; Thermo Fisher 
Scientific), and anti-chicken, Alexa Fluor 633-conjugated (1:250 dilution; catalogue number: A-21103; 
Thermo Fisher Scientific) secondary antibodies in TBS for 3 h at RT. Finally, after several washing 
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steps with TBS, the sections were mounted on glass slides using DAKO fluorescence mounting medium 
(catalogue number: S3023) and the slides were covered with high precision cover glass (Marienfeld No. 
1.5H, catalogue number: 0107222), and then sealed with nail polish.  
 
Processing of the Human Brain Tissue and Immunofluorescence Staining 
Brain was removed 2 h 22 min after death, both internal carotid and vertebral arteries were 
cannulated, and the brain was perfused first with physiological saline (1.5 L in 30 min) containing 5 mL 
of heparin, followed by a fixative solution containing 4% paraformaldehyde, 0.05% glutaraldehyde and 
0.2% picric acid in 0.1 M PB, pH 7.4 (4-5 L in 2 h). The temporal cortex was removed after perfusion 
and was post-fixed in the same fixative solution overnight without glutaraldehyde (9). Subsequently, 60 
µm-thick coronal sections were prepared from the blocks with a Leica VTS-1000 Vibratome (Leica 
Microsystems, Wetzlar, Germany) for immunostaining. The immunofluorescence staining was 
performed essentially the same manner as described above with differences as follows. To carry out the 
triple immunostaining, anti-C1qC (1:250 dilution; catalogue number: sc-27669; Santa Cruz 
Biotechnology), anti-cleaved caspase-3 (1:200 dilution; catalogue number: 9661; Cell Signaling 
Technology, Leiden, The Netherlands; previously validated to be specific to the active form (10)), and 
anti-Syp (1:250 dilution; catalogue number: 101 006; Synaptic Systems) antibodies were used. 
Subsequently, anti-goat Alexa Fluor 488-conjugated (1:400 dilution; catalogue number: 705-545-147; 
Jackson ImmunoResearch Laboratories, West Grove, PA, USA), anti-rabbit Cy3-conjugated (1:400 
dilution; catalogue number: 711-165-152; Jackson ImmunoResearch Laboratories), and anti-chicken 
Cy5-conjugated (1:400 dilution; catalogue number: 703-175-155; Jackson ImmunoResearch 
Laboratories) secondary antibodies were used. The sections were mounted on glass slides using Aqua-
Poly/Mount medium (Polysciences, Warrington, PA, USA), and the slides were covered with cover 
glass (Menzel Gläser, No. 1; catalogue number: CS2440100), and then sealed with nail polish. 
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Super-resolution Microscopy (STED, HyVolution 2) 
Stimulated emission depletion (STED) super-resolution and HyVolution 2 pseudo-super-
resolution (introduced by Leica) imaging was performed with a Leica TCS SP8 STED microscope 
(Leica Microsystems) using a Leica HC PL APO 100x STED white (1.4 NA) objective. For STED 
imaging, the stimulated emission depletion of the Alexa Fluor 514 and Alexa Fluor 546 fluorescence 
was carried out by using a beam shaped continuous wave 660 nm laser. The fluorescence of the Alexa 
Fluor 633 was detected in confocal mode without depletion. The fluorescence of each dye was detected 
sequentially by using a hybrid detector and spectral detections. The emissions of the Alexa Fluor 514, 
546 and 647 dyes were recorded in the 516-586 nm, 563-633 nm and 651-741 nm range, respectively. 
The pixel size of the recorded images was 20 nm/pixel. The images were restored by using Huygens Pro 
deconvolution and were analyzed with Leica LAS X 3.1.1 software. 
HyVolution 2 pseudo-super-resolution imaging was carried out on samples stained with Alexa 
Fluor 488, Cy3, and Cy5 dyes. The fluorescence of each dye was detected sequentially and spectrally 
by a hybrid detector at 499-569 nm, 565-635 nm, and 650-720 nm wavelengths, respectively. The 
pinhole diameter was set to 0.6 AU in each channel and the pixel size was 38 nm/pixel of the recorded 
images. Huygens Pro deconvolution software was used for image restoration and Leica LAS X 3.1.1 
software was used for image analysis.  
 
Fluorescence-activated Cell Sorting  
 The flow cytometry experiments were performed on a BD FACSAria III sorter (BD 
Biosciences, San Jose, CA, USA) coupled with BD FACSDiva software (BD Biosciences) for 
instrument operation, data acquisition, and analysis. A 633 nm and a 488 nm laser were utilized for 
fluorophore-excitation and a 70-µm nozzle was used to generate single droplets. The applied settings 
were as follows: forward light scatter (FSC) detector photomultiplier tube (PMT) gain setting = 350 V 
with a 1.5 neutral density filter; side light scatter (SSC) detector PMT gain setting = 600 V; FSC 
threshold = 5,000; SSC threshold = 2,000; allophycocyanin (APC) channel PMT gain setting = 508 V; 
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fluorescein isothiocyanate (FITC) channel PMT gain setting = 455 V. Sample dilution and flow rate 
were adjusted to optimal event recordings (below 20,000 processed events per sec). The population of 
synaptosomes was designated based on their FSC and SSC characteristics compared to that of the buffer 
alone, and further gating of fluorescent and non-fluorescent particles was performed among the 
members of this population. A fraction of synaptosomes, designated as the negative control, was labeled 
with the secondary antibody alone and the artificial background fluorescence was excluded according 
to the fluorescence intensity of this fraction. Fluorescently labeled C1q-tagged and unlabeled untagged 
synaptosomes were collected into separate tubes in „purity” sorting mode. Three million C1q-tagged 
and three million untagged synaptosomes were collected for the proteomics experiments and additional 
six million C1q-tagged and six million untagged synaptosomes for the Western blot investigations. After 
sorting, the samples were concentrated with 100K Amicon Ultra-15 Centrifugal Filter Units (Merck 
Millipore) and proteins were precipitated with the chloroform-methanol precipitation procedure (11). 
Precipitated proteins were resuspended in lysis buffer. 
 To determine the extent of synaptic co-localization of C1q with apoptotic markers (i.e., cleaved 
caspase-3 and annexin V), flow cytometry experiments were conducted as well. The amounts of double-
negative, C1q-labeled, cleaved caspase-3/annexin V-labeled, and double-positive synaptosomes were 
calculated from the data of 250,000 synaptosomes/experiment. Four independent experiments utilizing 
four mice were conducted for each apoptotic marker. Statistically significant differences were 
determined with two-tailed Student’s t-test of paired samples. 
 Flow cytometry data were processed and displayed with FCS Express 6 software (De Novo 
Software, Glendale, CA, USA). 
 
Proteomics Experiments 
 Two-dimensional difference gel electrophoresis (2D-DIGE) proteomics examination was 
conducted to compare the proteomes of sorted C1q-tagged and untagged synaptosomes from six mice. 
Due to the low protein yield obtainable from C1q-tagged synaptosomes, the 2D-DIGE saturation 
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labeling technique was chosen, which is suitable for the comparison of proteomes when the total protein 
amount is around a few µg. Our first investigations indicated that two million synaptosomes provide 
sufficient amount of protein for this technique. 
 Six fully independent samples were prepared using six adult male Crl:NMRI BR mice. A 
detailed protocol has been provided elsewhere (12, 13). All equipment and fluorescent dyes were 
purchased from GE Healthcare. A brief description is shown below, and experiment-specific details are 
noted. Proteins from two million C1q-tagged and two million untagged synaptosomes were labeled with 
Cy5 fluorescent dye, while a pooled sample was prepared containing proteins from one million C1q-
tagged and one million untagged synaptosomes together. The latter was labeled with Cy3 dye. C1q-
tagged and untagged synaptosome samples were prepared and run on separate gels together with the 
same amount of a pooled sample. Fluorescence intensity of the Cy5-labeled sample was normalized to 
the signal of the Cy3-labeled pooled sample on the same gel after the two-dimensional protein 
separation. 
 Proteins were first separated according to their isoelectric points, equilibrated under reducing 
conditions, and then separated according to their molecular weights. Fluorescence intensities of the 
protein spots were detected with a Typhoon TRIO+ fluorescence scanner. Protein spots were identified, 
matched, and manually verified as well using the DeCyder 2D Differential Analysis Software. 
Statistically significant differences were determined with Student’s t-test of paired samples in the 
software. Comparisons were performed between C1q-tagged and untagged synaptosomes from the same 
animals and significance level was set at P < 0.05. The significantly altered protein gel spots were 
manually excised from a preparative gel containing 800 µg total synaptosomal proteins. The gel spots 
were placed in 1% acetic acid solution and were stored at 4 °C until further protein identification. 
For the mass spectrometric protein identification, proteins were digested with Trypsin Gold 
(Promega, Madison, WI, USA) following the protocol by Shevchenko et al. (14) with minor 
modifications. The HPLC-MS/MS analysis of the tryptic peptide mixtures was performed using a 
nanoflow UHPLC system (Dionex UltiMate 3000 RSLCnano System, Thermo Scientific, Sunnyvale, 
CA, USA) coupled to a high-resolution QTOF mass spectrometer (Maxis II ETD, Bruker Daltonik 
GmbH, Bremen, Germany). The mass spectrometer was fitted with a CaptiveSpray source and a 
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nanoBooster tank. The nanoBooster was filled with acetonitrile operating with 0.2 bar N2-flow. The 
tryptic peptides were desalted online on an Acclaim Pepmap C18 trap column (100 μm i.d. × 20 mm; 
Thermo Scientific), and then separated on a reverse-phase Acclaim Pepmap RSLC analytical column 
(C18, 75 μm i.d. × 150 mm; Thermo Scientific). The elution of the peptides from the analytical column 
to the emitter tip was achieved using a flow rate of 300 nL/min and a 90 min long gradient going from 
2.5% to 45% solvent B (solvent A was water containing 0.1% formic acid and solvent B was acetonitrile 
containing 0.1% formic acid).  
Mass spectrometry used electrospray ionization in the positive-ion mode. Signal intensities were 
measured using single stage mass spectrometry (capillary voltage: 1.2 kV, drying gas flow: 3 L/min, gas 
temperature: 150 °C). Protein identification was performed using tandem mass spectrometry in 
AutoMS/MS setup (data-dependent analysis) from the m/z range of 300–2,200. Collision gas was N2 
and collision energy was varied in the 10–80 eV range according to predefined charge state-dependent 
configuration files. 
 Protein content, identified from data-dependent analysis measurements, was searched against 
the latest SwissProt sequence database with the taxonomy of Mus musculus using Mascot Server v.2.5 
(Matrix Science, London, UK). During the searching, one missed cleavage was allowed, 
carbamidomethyl cysteine was set as fixed modification, and methionine oxidation was allowed as 
variable modification. Proteins were accepted if a minimum of two unique peptides were identified. 
Protein data analysis was performed with ProteinScape v 3.0 bioinformatics platform (Bruker, Billerica, 
MA, USA). 
 
Bioinformatics Analysis 
 Functional classification of the altered proteins was conducted using the GeneOntology 
(http://www.geneontology.org) and UniProt (http://www.uniprot.org) databases as well as with the 
published literature. 
 Pathway analyses of the differentially regulated proteins were conducted using the Pathway 
Studio software (Elsevier Life Science Solutions). Common regulator and common target analyses were 
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performed using the “Sub-Network Enrichment Analysis” tool where all of the up- or downstream 
entities and types of connections present in the database were taken into account. Significantly enriched 
entities (P < 0.05, Fisher’s exact test) were ranked based on their calculated P-values. 
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Supplementary Figures and Tables 
 
 
Fig. S1. Characterization of the synaptosome fraction. (A, B) Electron micrographs of the synaptic 
fraction. Crowded membranous structures are visible (A), corresponding to detached synaptic vesicle-
filled presynaptic nerve terminals (PRE) connected to the postsynaptic compartment (POST) (B). (C) 
Manual analysis of the electron micrographs of the synaptosome fraction. The results are presented from 
thorough analysis of 5972 particles from 40 different images. (D) Western blot (WB) image and bar 
graphs showing enrichment of the synaptic markers Psd95 and Syp in the cortical synaptosome fraction 
compared to their levels in the whole cortical tissue homogenate (n = 5 biologically independent 
samples; fluorescence intensities were normalized to actin). (E) Light microscopy examination of 
synaptosomes. The differential interference contrast (DIC) image is presented both separately and 
overlaid with the fluorescence image showing Syp-positive synaptosomes. Synaptosomes became 
highly aggregated in PBS. (F) WB image demonstrating the presence of C1q in the cerebral cortices of 
healthy adult mice (n = at least 6 biologically independent samples). Means ± S.E.M. are shown. Scale 
bars are 2 µm (A), 0.25 µm (B), 20 µm (E). 
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Fig. S2. Flow cytometry analysis and sorting of synaptosomes. (A) Synaptosomes were analyzed 
individually without the presence of aggregates, as plotting their forward light scatter area (FSC-A) 
signal against their forward light scatter height (FSC-H) signal resulted in a diagonal distribution 
indicating the absence of synaptosome aggregates (representative image of at least 5 experiments). (B) 
Dot plot showing the homogeneous population of synaptosomes, considering their size (FSC-A axis) 
and inner complexity (side light scatter area (SSC-A) axis) (representative image of at least 15 
independent experiments). (C) Representative recording showing that synaptosomes were almost 
completely labeled with the viability dye calcein-AM (representative image of 4 independent 
experiments). (D) Electron micrograph of a sorted intact synaptosome. Scale bar is 0.25 µm. 
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Fig. S3. The percentage of C1q-positive synaptosomes under different conditions assessed using 
flow cytometry. Cerebral cortical synaptosomes isolated from mice at postnatal day 5 (P5) (n = 12 mice, 
pooled in groups of 3 before subcellular fractionation) and adult (3 months old) mice (n = 4-6 mice per 
experimental condition) were separately immunolabeled with two anti-C1q antibodies (polyclonal anti-
C1qA and monoclonal anti-C1q) using the same antibody dilution. Means ± S.E.M. are shown. * P < 
0.05, two-tailed independent Student’s t-test.  
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Fig. S4. Results of 2D-DIGE experiments. Representative gel image from the 2D-DIGE analysis of 
sorted synaptosomes showing the positions and level changes of altered proteins (representative image 
of 6 independent experiments). 
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Fig. S5. The identification of post-translationally modified forms of Nptx1. (A) Proteins of the 
synaptosome homogenate were separated using 2D gel electrophoresis. After blotting of the proteins, 
the membrane was stained with the total protein stain SYPRO Ruby (red) and labeled with anti-Nptx1 
antibody (green). According to our results, the post-translationally modified forms of the synaptic Nptx1 
are present (4 distinguishable Nptx1 protein spots are observable), which mostly differ in their 
isoelectric points (representative image of 4 independent experiments). (B) Comparison of the 2D-DIGE 
proteomics and 2D-immunoblot results revealed that the downregulated Nptx1 form is only one but the 
most abundant form of the four Nptx1 spots. The amounts of the other forms were too low to be 
quantified in the proteomics study. 
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Fig. S6. Bioinformatics analysis of the protein network altered upon C1q-tagging. “Ca2+” is the 
most significant upstream regulator, whereas the process of “Apoptosis” is the second highest-ranked 
downstream target of the set of altered proteins according to the bioinformatics analysis (using Fisher’s 
exact test). The thickness of an edge is proportional to the number of the corresponding references. 
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Fig. S7. STED-confocal combined microscopy images showing co-localization of C1q, cleaved 
caspase-3 and Syp on mouse brain sections. The circles indicate examples of co-localization between 
C1q, cleaved caspase-3 (both were visualized using STED super-resolution microscopy) and Syp 
(visualized using confocal microscopy) in the molecular layer of the hippocampal dentate gyrus. Scale 
bar is 0.5 µm. 
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Fig. S8. HyVolution 2 pseudo-super-resolution confocal microscopy images showing co-
localization of C1q, cleaved caspase-3 and Syp on human brain sections. The circles indicate 
examples of co-localization between C1q, cleaved caspase-3 and Syp in the temporal cortex (Brodmann 
area 38). Scale bar is 0.5 µm. 
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Fig. S9. Validation of the specificity of the used anti-cleaved caspase-3 antibody. Western blot image 
demonstrating that the used anti-cleaved caspase-3 antibody recognizes specifically the ~17 kDa cleaved 
fragment of the activated caspase-3 but not the inactive intact caspase-3 with molecular mass of ~31 
kDa. 
24 
 
# 
Fold change (C1q-
tagged/untagged) 
P-value Protein name Gene name 
Molecular 
mass (kDa) 
Calculated 
theoretical pI 
Number of identified 
unique peptides 
Sequence 
coverage (%) 
Primary cellular 
function 
1 -1.55 0.00071 Beta-synuclein  Sncb 14 4.4 10 91 Synaptic transmission 
2 -1.4 0.00079 
Alpha-enolase  Eno1 47.1 6.4 7 27.4 Glycolysis 
Neuronal pentraxin-1  Nptx1 47.1 6.1 5 15.7 Synaptic transmission 
3 1.32 0.0039 
Phosphatidylinositol transfer protein 
alpha isoform  
Pitpna 31.9 6 6 18.1 Signal transduction 
4 -1.29 0.0062 Peroxiredoxin-6  Prdx6 24.9 5.7 18 75 
Response to oxidative 
stress 
5 1.78 0.011 Actin, cytoplasmic 1  Actb 41.7 5.3 22 50.7 
Microfilament 
constituent 
6 -1.55 0.012 Tropomodulin-2  Tmod2 39.5 5.3 11 42.7 
Microfilament 
organization 
7 1.52 0.012 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1  
Gnb1 37.4 5.6 4 16.8 Signal transduction 
8 2.24 0.014 
Synapsin-2  Syn2 63.3 8.6 11 21.8 
Synaptic vesicle 
exocytosis 
ATP synthase subunit alpha, 
mitochondrial  
Atp5a1 59.7 9.2 9 21.3 Energy metabolism 
9 1.77 0.018 Actin, cytoplasmic 1  Actb 41.7 5.3 12 31.7 
Microfilament 
constituent 
10 2.12 0.021 Actin, cytoplasmic 1  Actb 41.7 5.3 2 7.2 
Microfilament 
constituent 
11 -1.6 0.025 Complexin-1 Cplx1 15.1 4.9 4 33.6 
Synaptic vesicle 
exocytosis 
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Table S1. List of proteins identified at significantly altered levels. Note that the same protein could be present in different protein spots if the level of different 
post-translational modifications of it exhibited statistically significant differences. In addition, more than one identified protein could contribute to the 
fluorescence intensity level of the same spot. 
  
12 -1.23 0.027 Proteasome subunit alpha type-5  Psma5 26.4 4.7 5 22.4 Protein degradation 
13 -1.25 0.035 
Ubiquitin carboxyl-terminal 
hydrolase isozyme L1  
Uchl1 24.8 5.1 18 80.7 Protein degradation 
14 -1.55 0.038 Calcineurin subunit B type 1  Ppp3r1 19.3 4.6 21 73.5 Signal transduction 
15 1.39 0.039 Aconitate hydratase, mitochondrial  Aco2 85.4 8.1 9 14.1 
Carbohydrate 
metabolism 
16 1.37 0.039 
14 kDa phosphohistidine 
phosphatase 
Phpt1 14 5.3 7 46 Unknown 
17 1.99 0.044 Fructose-bisphosphate aldolase A  Aldoa 39.3 8.3 17 49.2 Glycolysis 
18 -1.34 0.045 Peroxiredoxin-6  Prdx6 24.9 5.7 16 63.8 
Response to oxidative 
stress 
19 -1.45 0.048 
Voltage-dependent anion-selective 
channel protein 1  
Vdac1 32.3 8.6 6 15.5 Ion transport 
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Dataset S1. Result of the bioinformatics analysis using Pathway Studio. (S1A) The top 15 highest 
ranked entities (according to their Fisher’s exact test P values) up- and downstream of the altered 
proteins. (S1B) Manually validated references provided by Pathway Studio about the connections 
between the altered proteins and the process of apoptosis or Ca2+. 
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